No Association Between FTO Gene Polymorphisms and Central Nervous System Tumor Susceptibility in Chinese Children

References

• Wesseling P, Capper D. WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol. 2018;44(2):139–150. doi:10.1111/nan.12432
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16 Suppl 4:iv1–iv63. doi:10.1093/neuonc/nou223
   Web of Science ®Google Scholar
• Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98(21):1528–1537. doi:10.1093/jnci/djj411
   PubMedGoogle Scholar
• Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers. 2015;1:15017. doi:10.1038/nrdp.2015.17
   PubMed Web of Science ®Google Scholar
• Udaka YT, Packer RJ. Pediatric brain tumors. Neurol Clin. 2018;36(3):533–556. doi:10.1016/j.ncl.2018.04.009
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-1
   PubMed Web of Science ®Google Scholar
• Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017;40(1):1–14. doi:10.1007/s10143-016-0709-8
   PubMed Web of Science ®Google Scholar
• Jiang T, Nam DH, Ram Z, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2020. doi:10.1016/j.canlet.2020.10.050
   Web of Science ®Google Scholar
• Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113(7 Suppl):1953–1968. doi:10.1002/cncr.23741
   PubMed Web of Science ®Google Scholar
• Vienne-Jumeau A, Tafani C, Ricard D. Environmental risk factors of primary brain tumors: A review. Rev Neurol (Paris). 2019;175(10):664–678. doi:10.1016/j.neurol.2019.08.004
   PubMed Web of Science ®Google Scholar
• Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420–429. doi:10.1016/j.soncn.2018.10.001
   PubMed Web of Science ®Google Scholar
• Cordier D, Gerber M, Brand S. Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (WHO III and IV): study protocol for a randomized controlled trial. Cancer Commun (Lond). 2019;39(1):46. doi:10.1186/s40880-019-0390-8
   Web of Science ®Google Scholar
• Diwanji TP, Engelman A, Snider JW, Mohindra P. Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults. Adolesc Health Med Ther. 2017;8:99–113. doi:10.2147/AHMT.S53391
   PubMed Web of Science ®Google Scholar
• Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905–908. doi:10.1038/ng.408
   PubMed Web of Science ®Google Scholar
• Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899–904. doi:10.1038/ng.407
   PubMed Web of Science ®Google Scholar
• Melin BS, Barnholtz-Sloan JS, Wrensch MR, et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet. 2017;49(5):789–794. doi:10.1038/ng.3823
   Web of Science ®Google Scholar
• Kinnersley B, Labussiere M, Holroyd A, et al. Genome-wide association study identifies multiple susceptibility loci for glioma. Nat Commun. 2015;6:8559. doi:10.1038/ncomms9559
   PubMed Web of Science ®Google Scholar
• Yang T, Wen Y, Li J, et al. NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children. Exp Hematol Oncol. 2019;8:11. doi:10.1186/s40164-019-0135-z
   PubMed Web of Science ®Google Scholar
• Yang T, Wen Y, Li J, et al. Association of the TP53 rs1042522 C>G polymorphism and hepatoblastoma risk in Chinese children. J Cancer. 2019;10(15):3444–3449. doi:10.7150/jca.33063
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–894. doi:10.1126/science.1141634
   PubMed Web of Science ®Google Scholar
• Yang J, Loos RJ, Powell JE, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature. 2012;490(7419):267–272. doi:10.1038/nature11401
   PubMed Web of Science ®Google Scholar
• Ningombam SS, Chhungi V, Newmei MK, et al. Differential distribution and association of FTO rs9939609 gene polymorphism with obesity: A cross-sectional study among two tribal populations of India with East-Asian ancestry. Gene. 2018;647:198–204. doi:10.1016/j.gene.2018.01.009
   PubMed Web of Science ®Google Scholar
• Peters U, North KE, Sethupathy P, et al. A systematic mapping approach of 16q12.2/FTO and BMI in more than 20,000 African Americans narrows in on the underlying functional variation: results from the Population Architecture using Genomics and Epidemiology (PAGE) study. PLoS Genet. 2013;9(1):e1003171. doi:10.1371/journal.pgen.1003171
   PubMed Web of Science ®Google Scholar
• Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3(7):e115. doi:10.1371/journal.pgen.0030115
   PubMed Web of Science ®Google Scholar
• Sigurdson AJ, Brenner AV, Roach JA, et al. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population. Carcinogenesis. 2016;37(7):677–684. doi:10.1093/carcin/bgw047
   PubMed Web of Science ®Google Scholar
• Kaklamani V, Yi N, Sadim M, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52. doi:10.1186/1471-2350-12-52
   PubMed Web of Science ®Google Scholar
• Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet. 2013;45(4):428–32, 432e1. doi:10.1038/ng.2571
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–887. doi:10.1038/nchembio.687
   PubMed Web of Science ®Google Scholar
• Zhou C, Zhang Z, Zhu X, et al. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine. 2020;59:102955. doi:10.1016/j.ebiom.2020.102955
   PubMed Web of Science ®Google Scholar
• Jin H, Ying X, Que B, et al. N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer. EBioMedicine. 2019;47:195–207. doi:10.1016/j.ebiom.2019.07.068
   PubMed Web of Science ®Google Scholar
• Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18(1):103. doi:10.1186/s12943-019-1033-z
   PubMed Web of Science ®Google Scholar
• Chai RC, Wu F, Wang QX, et al. m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas. Aging (Albany NY). 2019;11(4):1204–1225. doi:10.18632/aging.101829
   PubMedGoogle Scholar
• Zhuo ZJ, Liu W, Zhang J, et al. Functional polymorphisms at ERCC1/XPF genes confer neuroblastoma risk in Chinese children. EBioMedicine. 2018;30:113–119. doi:10.1016/j.ebiom.2018.03.003
   PubMed Web of Science ®Google Scholar
• Zhuo ZJ, Hua RX, Chen Z, et al. WTAP gene variants confer hepatoblastoma susceptibility: a seven-center case-control study. Mol Ther Oncolytics. 2020;18:118–125. doi:10.1016/j.omto.2020.06.007
   PubMed Web of Science ®Google Scholar
• Zhuo Z, Zhou C, Fang Y, et al. Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children. Cancer Commun (Lond). 2020;40(11):641–646. doi:10.1002/cac2.12088
   PubMed Web of Science ®Google Scholar
• Li Z, Weng H, Su R, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31(1):127–141. doi:10.1016/j.ccell.2016.11.017
   PubMed Web of Science ®Google Scholar
• Xu Y, Ye S, Zhang N, et al. The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun (Lond). 2020;40(10):484–500. doi:10.1002/cac2.12075
   PubMed Web of Science ®Google Scholar
• Huang H, Wang Y, Kandpal M, et al. FTO-dependent N (6)-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling. Cancer Res. 2020;80(16):3200–3214. doi:10.1158/0008-5472.CAN-19-4044
   Web of Science ®Google Scholar
• Cui Q, Shi H, Ye P, et al. m(6)A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep. 2017;18(11):2622–2634. doi:10.1016/j.celrep.2017.02.059
   PubMed Web of Science ®Google Scholar
• Xiao L, Li X, Mu Z, et al. FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma. Cancer Res. 2020;80(18):3945–3958. doi:10.1158/0008-5472.CAN-20-0132
   PubMed Web of Science ®Google Scholar
• Tao B, Huang X, Shi J, et al. FTO interacts with FOXO3a to enhance its transcriptional activity and inhibits aggression in gliomas. Signal Transduct Target Ther. 2020;5(1):130. doi:10.1038/s41392-020-00234-3
   Web of Science ®Google Scholar
• Gaudet MM, Yang HP, Bosquet JG, et al. No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19(8):2106–2109. doi:10.1158/1055-9965.EPI-10-0515
   PubMed Web of Science ®Google Scholar
• Zeng X, Ban Z, Cao J, et al. Association of FTO mutations with risk and survival of breast cancer in a Chinese population. Dis Markers. 2015;2015:101032. doi:10.1155/2015/101032
   Web of Science ®Google Scholar